Professor Anthony Hollander

Team of Experts from University of Liverpool Spin-Out Sulantrix Using AI and Multi-omics Platforms to Develop New Cancer Treatments

(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines…

1 year ago

Three new appointments to University of Liverpool senior leadership team

LIVERPOOL, 24-Jul-2017 — /EuropaWire/ — The University has announced three new appointments to its senior leadership team. Professor Louise Kenny has been…

7 years ago

University of Liverpool’s Professor Anthony Hollander presented Regenerative Medicine evidence to the House of Commons Science and Technology Committee

LIVERPOOL, 22-Jul-2016 — /EuropaWire/ — Professor Anthony Hollander, from the University of Liverpool’s Institute of Integrative Biology, has presented evidence to the…

8 years ago

University of Liverpool scientist’s company awarded £2 million to develop stem cell technologies for treatment of damaged fibrous tissues in the knee

A company, founded by University of Liverpool scientist, Professor Anthony Hollander, has been awarded £2 million to develop stem cell…

9 years ago